2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·7 t sitten · MuokattuIt's a gift that keeps on giving. First, I just want to correct TS; he claimed that Weeco Astrum 10/10 temporarily lost its subsidy, just like the flowers. I want to state unequivocally that the persons who were undergoing treatment with oil, including Weeco Astrum 10/10, have at no point had their subsidy withdrawn after July 10th, when the law was passed. It was only the flowers that lost the subsidy. The Medical Association and the health insurance funds are still bickering over the legislation of July 10th. But they still agree that people who were undergoing treatment with flowers before July 30th, 2026, could switch directly to oil, including Weeco Astrum 10/10, without a waiting period if the doctor assesses it, and the same applies to oil; they retain the same subsidy status. As well as that those who cannot tolerate or for other reasons cannot tolerate other medicine also avoid the waiting period. What they are still arguing about, among other things, is that doctors want broader self-determination. The German healthcare system is extremely complicated. They also hate the reimbursement system if a doctor exceeds their budget. You wouldn't believe it, but doctors have to pay out of their own pocket if they exceed the budget. When there is 100% reimbursement, as with Weeco Astrum 10/10, doctors do not risk having to reimburse, and therefore they are also more willing to prescribe this particular oil. https://businessofcannabis.com/germanys-medical-cannabis-insurance-reform-descends-into-chaos-as-regulators-turn-on-each-other/- ·18 t sittenThere is an interview with the management on the stock debate site Proinvestor.com. I can recommend listening to it. Here, in a few minutes and from the management's own mouth, one can get both a relevant and not least correct insight into what is happening in Germany and France. Then one doesn't need to read the catastrophically flawed and massive hype that fills this chat.
·1 päivä sittenThe company writes in capital letters "positive operating cash flow of DKK 1,6 million" as one of four main highlights. But when you decompose the figure, it looks different. The period's result H1 is minus 882 t. Reversals of depreciation give plus 923 t. And then comes the large item: working capital change of plus 1.812 t. In other words: 96 % of the cash flow comes from working capital release. Not from operations. So where do the 1,8 mio. come from? Inventory has been cut by 70 % (from 1.082 t to 321 t) – freed up 761 t in cash. Other liabilities have almost doubled (from 875 t to 1.641 t) – freed up an additional 765 t. To put it plainly: the company has eaten into inventory and postponed payments. These are one-off effects, not earned cash. Inventory must be replenished in H2, and the liabilities (presumably holiday pay, VAT, bonuses) must be paid sooner or later. The best test is the cash itself. It has only increased by 702 t in the entire H1 (from 1.033 t to 1.735 t). Not 1,6 mio. Not even close. And for perspective: STENOCARE stand-alone had a working capital change of minus 2,1 mio. in H1-2025. Now it is suddenly plus 1,8 mio. A swing of almost 4 mio. in one line – probably the CannGros merger's opening balance more than organic operations. So why is the market cheering? Because headlines are easy, and decomposition is difficult. "DKK 4 mio. revenue, +133 % YoY, positive cash flow" sells itself. Reading the cash flow statement line by line and cross-checking the balance sheet requires time that few people spend. Confirmation bias does the rest – people holding shares need signs that the case is turning around. The Q2 report is not bad. The top line beat expectations, EBITDA remains positive for the fifth consecutive quarter, the company is alive. But it is far from the strong report that the press release portrays it as. The cash flow strength is one-off effects disguised as operational improvement.blueoceanguy have you seen the webcast? Everything you write, you have from the financial report that was published yesterday morning at 8 AM. Based on what you write, you are questioning that there is an earning of approx. 1,8 million kroner, where it is not clearly stated where they come from, but you are guessing, based on what you can read in the financial report. In the webcast, PJ clearly states that operating expenses have been unchanged, there have been some fees, but it has not broken the budget. It also seems like you are trying to make sense of there being a profit of 702.000kr, (as you write that it says there is in the cash) and rightly so you question this amount. How can they write that it is only 702.000 kr. where has the rest gone? 1,8 million kroner but only 702.000 kr in profit has been reported, and PJ said yesterday that operations are the same as Q1, so it is not from operations that they have generated these 1,8 million, and there is a difference of 1.098.000 kr. based on what you have read in the financial report. So if it doesn't come from operations, then they must have earned the money from the oil. Based on what we can read in the financial report, it clearly states. Germany has not contributed significantly to the earnings. At the very end of the mentioned Webcast, TS says that precisely because the oil is standardized, it is very popular in Germany. If the oil is very popular in Germany, how can that then be consistent with the German market not having contributed significantly to the earnings in Q2. My qualified guess is that the money you cannot place anywhere, probably comes from the earnings from Germany. How can it be that PJ and TS are not celebrating, as they have done for the last four quarters? The questions are lining up for me. When I write qualified guess, it is because I still trust the research I have conducted since May 13.- ·1 päivä sittenHas anyone actually read the cash flow statement in detail, or are we all just looking at the press release's headline?
1 päivä sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sitten · MuokattuIt's a gift that keeps on giving. First, I just want to correct TS; he claimed that Weeco Astrum 10/10 temporarily lost its subsidy, just like the flowers. I want to state unequivocally that the persons who were undergoing treatment with oil, including Weeco Astrum 10/10, have at no point had their subsidy withdrawn after July 10th, when the law was passed. It was only the flowers that lost the subsidy. The Medical Association and the health insurance funds are still bickering over the legislation of July 10th. But they still agree that people who were undergoing treatment with flowers before July 30th, 2026, could switch directly to oil, including Weeco Astrum 10/10, without a waiting period if the doctor assesses it, and the same applies to oil; they retain the same subsidy status. As well as that those who cannot tolerate or for other reasons cannot tolerate other medicine also avoid the waiting period. What they are still arguing about, among other things, is that doctors want broader self-determination. The German healthcare system is extremely complicated. They also hate the reimbursement system if a doctor exceeds their budget. You wouldn't believe it, but doctors have to pay out of their own pocket if they exceed the budget. When there is 100% reimbursement, as with Weeco Astrum 10/10, doctors do not risk having to reimburse, and therefore they are also more willing to prescribe this particular oil. https://businessofcannabis.com/germanys-medical-cannabis-insurance-reform-descends-into-chaos-as-regulators-turn-on-each-other/
- ·18 t sittenThere is an interview with the management on the stock debate site Proinvestor.com. I can recommend listening to it. Here, in a few minutes and from the management's own mouth, one can get both a relevant and not least correct insight into what is happening in Germany and France. Then one doesn't need to read the catastrophically flawed and massive hype that fills this chat.
- ·1 päivä sittenThe company writes in capital letters "positive operating cash flow of DKK 1,6 million" as one of four main highlights. But when you decompose the figure, it looks different. The period's result H1 is minus 882 t. Reversals of depreciation give plus 923 t. And then comes the large item: working capital change of plus 1.812 t. In other words: 96 % of the cash flow comes from working capital release. Not from operations. So where do the 1,8 mio. come from? Inventory has been cut by 70 % (from 1.082 t to 321 t) – freed up 761 t in cash. Other liabilities have almost doubled (from 875 t to 1.641 t) – freed up an additional 765 t. To put it plainly: the company has eaten into inventory and postponed payments. These are one-off effects, not earned cash. Inventory must be replenished in H2, and the liabilities (presumably holiday pay, VAT, bonuses) must be paid sooner or later. The best test is the cash itself. It has only increased by 702 t in the entire H1 (from 1.033 t to 1.735 t). Not 1,6 mio. Not even close. And for perspective: STENOCARE stand-alone had a working capital change of minus 2,1 mio. in H1-2025. Now it is suddenly plus 1,8 mio. A swing of almost 4 mio. in one line – probably the CannGros merger's opening balance more than organic operations. So why is the market cheering? Because headlines are easy, and decomposition is difficult. "DKK 4 mio. revenue, +133 % YoY, positive cash flow" sells itself. Reading the cash flow statement line by line and cross-checking the balance sheet requires time that few people spend. Confirmation bias does the rest – people holding shares need signs that the case is turning around. The Q2 report is not bad. The top line beat expectations, EBITDA remains positive for the fifth consecutive quarter, the company is alive. But it is far from the strong report that the press release portrays it as. The cash flow strength is one-off effects disguised as operational improvement.blueoceanguy have you seen the webcast? Everything you write, you have from the financial report that was published yesterday morning at 8 AM. Based on what you write, you are questioning that there is an earning of approx. 1,8 million kroner, where it is not clearly stated where they come from, but you are guessing, based on what you can read in the financial report. In the webcast, PJ clearly states that operating expenses have been unchanged, there have been some fees, but it has not broken the budget. It also seems like you are trying to make sense of there being a profit of 702.000kr, (as you write that it says there is in the cash) and rightly so you question this amount. How can they write that it is only 702.000 kr. where has the rest gone? 1,8 million kroner but only 702.000 kr in profit has been reported, and PJ said yesterday that operations are the same as Q1, so it is not from operations that they have generated these 1,8 million, and there is a difference of 1.098.000 kr. based on what you have read in the financial report. So if it doesn't come from operations, then they must have earned the money from the oil. Based on what we can read in the financial report, it clearly states. Germany has not contributed significantly to the earnings. At the very end of the mentioned Webcast, TS says that precisely because the oil is standardized, it is very popular in Germany. If the oil is very popular in Germany, how can that then be consistent with the German market not having contributed significantly to the earnings in Q2. My qualified guess is that the money you cannot place anywhere, probably comes from the earnings from Germany. How can it be that PJ and TS are not celebrating, as they have done for the last four quarters? The questions are lining up for me. When I write qualified guess, it is because I still trust the research I have conducted since May 13.
- ·1 päivä sittenHas anyone actually read the cash flow statement in detail, or are we all just looking at the press release's headline?
- 1 päivä sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sitten · MuokattuIt's a gift that keeps on giving. First, I just want to correct TS; he claimed that Weeco Astrum 10/10 temporarily lost its subsidy, just like the flowers. I want to state unequivocally that the persons who were undergoing treatment with oil, including Weeco Astrum 10/10, have at no point had their subsidy withdrawn after July 10th, when the law was passed. It was only the flowers that lost the subsidy. The Medical Association and the health insurance funds are still bickering over the legislation of July 10th. But they still agree that people who were undergoing treatment with flowers before July 30th, 2026, could switch directly to oil, including Weeco Astrum 10/10, without a waiting period if the doctor assesses it, and the same applies to oil; they retain the same subsidy status. As well as that those who cannot tolerate or for other reasons cannot tolerate other medicine also avoid the waiting period. What they are still arguing about, among other things, is that doctors want broader self-determination. The German healthcare system is extremely complicated. They also hate the reimbursement system if a doctor exceeds their budget. You wouldn't believe it, but doctors have to pay out of their own pocket if they exceed the budget. When there is 100% reimbursement, as with Weeco Astrum 10/10, doctors do not risk having to reimburse, and therefore they are also more willing to prescribe this particular oil. https://businessofcannabis.com/germanys-medical-cannabis-insurance-reform-descends-into-chaos-as-regulators-turn-on-each-other/
- ·18 t sittenThere is an interview with the management on the stock debate site Proinvestor.com. I can recommend listening to it. Here, in a few minutes and from the management's own mouth, one can get both a relevant and not least correct insight into what is happening in Germany and France. Then one doesn't need to read the catastrophically flawed and massive hype that fills this chat.
- ·1 päivä sittenThe company writes in capital letters "positive operating cash flow of DKK 1,6 million" as one of four main highlights. But when you decompose the figure, it looks different. The period's result H1 is minus 882 t. Reversals of depreciation give plus 923 t. And then comes the large item: working capital change of plus 1.812 t. In other words: 96 % of the cash flow comes from working capital release. Not from operations. So where do the 1,8 mio. come from? Inventory has been cut by 70 % (from 1.082 t to 321 t) – freed up 761 t in cash. Other liabilities have almost doubled (from 875 t to 1.641 t) – freed up an additional 765 t. To put it plainly: the company has eaten into inventory and postponed payments. These are one-off effects, not earned cash. Inventory must be replenished in H2, and the liabilities (presumably holiday pay, VAT, bonuses) must be paid sooner or later. The best test is the cash itself. It has only increased by 702 t in the entire H1 (from 1.033 t to 1.735 t). Not 1,6 mio. Not even close. And for perspective: STENOCARE stand-alone had a working capital change of minus 2,1 mio. in H1-2025. Now it is suddenly plus 1,8 mio. A swing of almost 4 mio. in one line – probably the CannGros merger's opening balance more than organic operations. So why is the market cheering? Because headlines are easy, and decomposition is difficult. "DKK 4 mio. revenue, +133 % YoY, positive cash flow" sells itself. Reading the cash flow statement line by line and cross-checking the balance sheet requires time that few people spend. Confirmation bias does the rest – people holding shares need signs that the case is turning around. The Q2 report is not bad. The top line beat expectations, EBITDA remains positive for the fifth consecutive quarter, the company is alive. But it is far from the strong report that the press release portrays it as. The cash flow strength is one-off effects disguised as operational improvement.blueoceanguy have you seen the webcast? Everything you write, you have from the financial report that was published yesterday morning at 8 AM. Based on what you write, you are questioning that there is an earning of approx. 1,8 million kroner, where it is not clearly stated where they come from, but you are guessing, based on what you can read in the financial report. In the webcast, PJ clearly states that operating expenses have been unchanged, there have been some fees, but it has not broken the budget. It also seems like you are trying to make sense of there being a profit of 702.000kr, (as you write that it says there is in the cash) and rightly so you question this amount. How can they write that it is only 702.000 kr. where has the rest gone? 1,8 million kroner but only 702.000 kr in profit has been reported, and PJ said yesterday that operations are the same as Q1, so it is not from operations that they have generated these 1,8 million, and there is a difference of 1.098.000 kr. based on what you have read in the financial report. So if it doesn't come from operations, then they must have earned the money from the oil. Based on what we can read in the financial report, it clearly states. Germany has not contributed significantly to the earnings. At the very end of the mentioned Webcast, TS says that precisely because the oil is standardized, it is very popular in Germany. If the oil is very popular in Germany, how can that then be consistent with the German market not having contributed significantly to the earnings in Q2. My qualified guess is that the money you cannot place anywhere, probably comes from the earnings from Germany. How can it be that PJ and TS are not celebrating, as they have done for the last four quarters? The questions are lining up for me. When I write qualified guess, it is because I still trust the research I have conducted since May 13.
- ·1 päivä sittenHas anyone actually read the cash flow statement in detail, or are we all just looking at the press release's headline?
- 1 päivä sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt